Intrathecal IgG synthesis and autoantibody-secreting cells in multiple sclerosis

Journal of Neuroimmunology

Volumn 108, Issue 1-2, 2000, Pages 207-215

  Sellebjerg, Finn ^a,b   Jensen, Claus V ^a   Christiansen, Michael ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Autoantibodies; Immunoglobulin G; Multiple sclerosis; Myelin basic protein; Proteolipid protein

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN;

ADULT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; CEREBROSPINAL FLUID; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW;

EID: 0034255925     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00292-7     Document Type: Article

References (66)

1. Andersson, M., Alvarez Cermeno, J., Bernardi, G., Cogato, I., Fredman, P., Frederiksen, J., Fredrikson, S., Gallo, P., Grimaldi, L.M., Gronning, M. et al., 1994. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J. Neurol. Neurosurg. Psychiatry 57, 897-902.
2. Annunziata, P., Pluchino, S., Martino, T., Guazzi, G., 1997. High levels of cerebrospinal fluid IgM binding to myelin basic protein are associated with early benign course in multiple sclerosis. J. Neuroimmunol. 77, 128-133.
3. Asakura, K., Pogulis, R.J., Pease, L.R., Rodriguez, M., 1996. A monoclonal autoantibody which promotes central nervous system remyelination is highly polyreactive to multiple known and novel antigens. J. Neuroimmunol. 65, 11-19.
4. Baig, S., Olsson, T., Yu Ping, J., Hojeberg, B., Cruz, M., Link, H., 1991. Multiple sclerosis: cells secreting antibodies against myelin-associated glycoprotein are present in cerebrospinal fluid. Scand. J. Immunol. 33, 73-79.
5. Brokstad, K.A., Page, M., Nyland, H., Haaheim, L.R., 1994. Autoantibodies to myelin basic protein are not present in the serum and CSF of MS patients. Acta Neurol. Scand. 89, 407-411.
6. Brüggemann, M., Williams, G.T., Bindon, C.I., Clark, M.R., Walker, M.R., Jefferis, R., Waldmann, H., Neuberger, M.S., 1987. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J. Exp. Med. 166, 1351-1361.
7. Cash, E., Weeth, S., Voltz, R., Kornhuber, M., 1992. Cells of cerebrospinal fluid of multiple sclerosis patients secrete antibodies to myelin basic protein in vitro. Scand. J. Immunol. 35, 695-701.
8. Chou, C.H., Tourtellotte, W.W., Kibler, R.F., 1983. Failure to detect antibodies to myelin basic protein or peptic fragments of myelin basic protein in CSF of patients with MS. Neurology 33, 24-28.
9. Colombo, E., Banki, K., Tatum, A.H., Daucher, J., Ferrante, P., Murray, R.S., Phillips, P.E., Perl, A., 1997. Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis. J. Clin. Invest. 99, 1238-1250.
10. Cruz, M., Olsson, T., Ernerudh, J., Hojeberg, B., Link, H., 1987. Immunoblot detection of oligoclonal anti-myelin basic protein IgG antibodies in cerebrospinal fluid in multiple sclerosis. Neurology 37, 1515-1519.
11. Deibler, G.E., Martenson, R.E., Kies, M.W., 1972. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 21, 2971-2976.
12. Frederiksen, J.L., Larsson, H.B., Olesen, J., 1992. Correlation of magnetic resonance imaging and CSF findings in patients with acute monosymptomatic optic neuritis. Acta Neurol. Scand. 86, 317-322.
13. Frederiksen, J.L., Larsson, H.B.W., Christiansen, P., Sellebjerg, F.T., Olesen, J., 1996. Blood-brain barrier impairment in acute optic neuritis evaluated by gadolinium-DTPA enhanced MRI and CSF studies. Eur. J. Neurol. 3, 560-566.
14. Garcia Merino, A., Persson, M.A., Ernerudh, J., Diaz Gil, J.J., Olsson, T., 1986. Serum and cerebrospinal fluid antibodies against myelin basic protein and their IgG subclass distribution in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 49, 1066-1070.
15. Gay, D., Esiri, M., 1991. Blood-brain barrier damage in acute multiple sclerosis plaques. Brain 114, 557-572.
16. Gay, F.W., Drye, T.J., Dick, G.W.A., Esiri, M.M., 1997. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. Brain 120, 1461-1483.
17. Genain, C.P., Cannella, B., Hauser, S.L., Raine, C.S., 1999. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5, 170-175.
18. Gerritse, K., Deen, C., Fasbender, M., Ravid, R., Boersma, W., Claassen, E., 1994. The involvement of specific anti myelin basic protein antibody-forming cells in multiple sclerosis immunopathology. J. Neuroimmunol. 49, 153-159.
19. Hampson, D.R., Poduslo, S.E., 1986. Purification of proteolipid protein and production of specific antiserum. J. Neuroimmunol. 11, 117-129.
20. Karni, A., Bakimer-Kleiner, R., Abramsky, O., Ben-Nun, A., 1999. Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis. Arch. Neurol. 56, 311-315.
21. Kaveri, S.V., Lacroix-Desmazes, S., Mouthon, L., Kazatchkine, M.D., 1998. Human natural autoantibodies: lessons from physiology and prospects for therapy. Immunologist 6, 227-233.
22. Kurtzke, J.F., 1983. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33, 1444-1452.
23. Lennon, V., Mackay, I.R., 1972. Binding of 125 I myelin basic protein by serum and cerebrospinal fluid. Clin. Exp. Immunol. 11, 595-603.
24. Link, H., Baig, S., Olsson, O., Jiang, Y.P., Hojeberg, B., Olsson, T., 1990. Persistent anti-myelin basic protein IgG antibody response in multiple sclerosis cerebrospinal fluid. J. Neuroimmunol. 28, 237-248.
25. Lucchinetti, C.F., Brück, W., Rodriguez, M., Lassmann, H., 1996. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol. 6, 259-274.
26. Lumsden, C.E., 1971. The immunogenesis of the multiple sclerosis plaque. Brain Res. 28, 365-390.
27. Mathiesen, T., von Holst, H., Fredrikson, S., Wirsen, G., Hederstedt, B., Norrby, E., Sundqvist, V.A., Wahren, B., 1989. Total, anti-viral, and anti-myelin IgG subclass reactivity in inflammatory diseases of the central nervous system. J. Neurol. 236, 238-242.
28. Matsiota, P., Blancher, A., Doyon, B., Guilbert, B., Clanet, M., Kouvelas, E.D., Avrameas, S., 1988. Comparative study of natural autoantibodies in the serum and cerebrospinal fluid of normal individuals and patients with multiple sclerosis and other neurological diseases. Ann. Inst. Pasteur Immunol. 139, 99-108.
29. Olsson, T., Baig, S., Hojeberg, B., Link, H., 1990. Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis. Ann. Neurol. 27, 132-136.
30. Panitch, H.S., Hooper, C.J., Johnson, K.P., 1980. CSF antibody to myelin basic protein. Measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis. Arch. Neurol. 37, 206-209.
31. Paolino, E., Fainardi, E., Ruppi, P., Tola, M.R., Govoni, V., Casetta, I., Monetti, V.C., Granieri, E., Carreras, M., 1996. A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 60, 572-575.
32. Paty, D.W., Oger, J.J., Kastrukoff, L.F., Hashimoto, S.A., Hooge, J.P., Eisen, A.A., Eisen, K.A., Purves, S.J., Low, M.D., Brandejs, V. et al., 1988. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38, 180-185.
33. Perez, L., Alvarez Cermeno, J.C., Rodriguez, C., Roldan, E., Brieva, J.A., 1995. B cells capable of spontaneous IgG secretion in cerebrospinal fluid from patients with multiple sclerosis: dependency on local IL-6 production. Clin. Exp. Immunol. 101, 449-452.
34. Poser, C.M., Paty, D.W., Scheinberg, L., McDonald, W.I., Davis, F.A., Ebers, G.C., Johnson, K.P., Sibley, W.A., Silberberg, D.H., Tourtellotte, W.W., 1983. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13, 227-231.
35. Prineas, J.W., Graham, J.S., 1981. Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown. Ann. Neurol. 10, 149-158.
36. Qin, Y., Duquette, P., Zhang, Y., Talbot, P., Poole, R., Antel, J., 1998. Clonal expansion and somatic hypermutation of VH genes of B cells from cerebrospinal fluid in multiple sclerosis. J. Clin. Invest. 102, 1045-1050.
37. Raine, C.S., Cannella, B., Hauser, S.L., Genain, C.P., 1999. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann. Neurol. 46, 144-160.
38. Rovaris, M., Filippi, M., 1999. Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis. Curr. Opin. Neurol. 12, 337-344.
39. Scolding, N.J., Morgan, B., Compston, D.A.S., 1998. The expression of complement regulatory proteins by adult human oligodendrocytes. J. Neuroimmunol. 84, 69-75.
40. S¢rensen, T.L., Ransohoff, R.M., 1998. Etiology and pathogenesis of multiple sclerosis. Semin. Neurol. 18, 287-294.
41. Sellebjerg, F., Christiansen, M., 1996. Qualitative assessment of intrathecal IgG synthesis by isoelectric focusing and immunodetection: interlaboratory reproducibility and interobserver agreement. Scand. J. Clin. Lab. Invest. 56, 135-143.
42. Sellebjerg, F.T., Frederiksen, J.L., Olsson, T., 1994a. Anti-myelin basic protein and anti-proteolipid protein antibody-secreting cells in the cerebrospinal fluid of patients with acute optic neuritis. Arch. Neurol. 51, 1032-1036.
43. Sellebjerg, F., Frederiksen, J.L., Olsson, T., Link, H., Madsen, H.O., Ryder, L.P., Svejgaard, A., 1994b. Peptide specificity of anti-myelin basic protein antibodies in patients with acute optic neuritis and the HLA system. Scand. J. Immunol. 39, 575-580.
44. Sellebjerg, F., Madsen, H.O., Frederiksen, J.L., Ryder, L.P., Svejgaard, A., 1995. Acute optic neuritis: myelin basic protein and proteolipid protein antibodies, affinity, and the HLA system. Ann. Neurol. 38, 943-950.
45. Sellebjerg, F., Chnstiansen, M., Nielsen, P.M., Frederiksen, J.L., 1998. Cerebrospinal fluid measures of disease activity in multiple sclerosis. Multiple Sclerosis 4, 475-479.
46. Sharief, M.K., Thompson, E.J., 1991. The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis. Ann. Neurol. 29, 147-151.
47. Storch, M.K., Piddlesden, S., Haltia, M., Iivanainen, M., Morgan, P., Lassman, H., 1998. Multiple sclerosis: in situ evidence for antibody-and complement-mediated demyelination. Ann. Neurol. 43, 465-471.
48. Sun, J.B., Olsson, T., Wang, W.Z., Xiao, B.G., Kostulas, V., Frednkson, S., Ekre, H.P., Link, H., 1991a. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur. J. Immunol. 21, 1461-1468.
49. Sun, J., Link, H., Olsson, T., Xiao, B.G., Andersson, G., Ekre, H.P., Linington, C., Diener, P., 1991b. T and B cell responses to myelinoligodendrocyte glycoprotein in multiple sclerosis. J. Immunol. 146, 1490-1495.
50. Söderström, M., Link, H., Xu, Z., Fredriksson, S., 1993. Optic neuritis and multiple sclerosis: anti-MBP and anti-MBP peptide antibody-secreting cells are accumulated in CSF. Neurology 43, 1215-1222.
51. Söderström, M., Lindqvist, M., Hillert, J., Käll, T.-B., Link, H., 1994a. Optic neuritis: findings on MR, CSF examination and HLA class II typing in 60 patients and results of a short-term follow-up. J. Neurol. 241, 391-397.
52. Söderström, M., Link, H., Fredrikson, S., Sun, J.-B., 1994b. Optic neuritis and multiple sclerosis: the T cell repertoires to myelin proteins and MBP peptides change with time. Acta Neurol. Scand. 90, 10-18.
53. Söderström, M., Jin, Y.-P., Hillert, J., Link, H., 1998. Optic neuritis. Prognosis for multiple sclerosis from MRI, CSF, and HLA findings. Neurology 50, 708-714.
54. Tumani, H., Tourtellotte, W.W., Peter, J.B., Felgenhauer, K., The Optic Neuritis Study Group, X., 1998. Acute optic neuritis: combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis. J. Neurol. Sci. 155, 44-49.
55. Tuohy, V.K., Yu, M., Yin, L., Kawczak, J.A., Kinkel, R.P., 1999. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. J. Exp. Med. 189, 1033-1042.
56. van der Goes, A., Kortekaas, M., Hoekstra, K., Dijkstra, C.D., Amor, S., 1999. The role of anti-myelin (auto)-antibodies in the phagocytosis of myelin by macrophages. J. Neuroimmunol. 101, 61-67.
57. van Engelen, B.G.M., Lamers, K.J.B., Gabreels, F.J.M., Wevers, R.A., van Geel, W.J.A., Borm, G.F., 1992. Age-related changes of neuron-specific enolase, S-100 protein, and myelin basic protein concentrations in cerebrospinal fluid. Clin. Chem. 38, 813-816.
58. Vass, K., Heininger, K., Schafer, B., Linington, C., Lassmann, H., 1992. Interferon-gamma potentiates antibody-mediated demyelination in vivo. Ann. Neurol. 32, 198-206.
59. Wajgt, A., Gorny, M., 1983. CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies. Acta Neurol. Scand. 68, 337-343.
60. Warren, K.G., Catz, I., 1987. A correlation between cerebrospinal fluid myelin basic protein and anti-myelin basic protein in multiple sclerosis patients. Ann. Neurol. 21, 183-189.
61. Warren, K.G., Catz, I., 1988. Neutralization of anti-myelin basic protein by cerebrospinal fluid of multiple sclerosis patients in clinical remission. J. Neurol. Sci. 88, 185-194.
62. Warren, K.G., Catz, I., 1990. A myelin basic protein antibody cascade in purified IgG from cerebrospinal fluid of multiple sclerosis patients. J. Neurol. Sci. 96, 19-27.
63. Warren, K.G., Catz, I., 1993. Increased synthetic peptide specificity of tissue-CSF bound anti-MBP in multiple sclerosis. J. Neuroimmunol. 43, 87-96.
64. Warren, K.G., Catz, I., Johnson, E., Mielke, B., 1994. Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis. Ann. Neurol. 35, 280-289.
65. Woyciechowska, J.L., Brzosko, W.J., 1977. Immunofluorescence study of brain plaques from two patients with multiple sclerosis. Neurology 27, 620-622.
66. Xiao, B.G., Linington, C., Link, H., 1991. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J. Neuroimmunol. 31, 91-96.